237 related articles for article (PubMed ID: 23000439)
1. Kissing drug-eluting balloons for the treatment of unprotected distal left main bifurcation drug-eluting stent restenosis.
Ielasi A; Anzuini A
Cardiovasc Revasc Med; 2012; 13(6):347-9. PubMed ID: 23000439
[TBL] [Abstract][Full Text] [Related]
2. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome after management of unprotected left main in-stent restenosis after bare metal or drug-eluting stents.
Chen SL; Xu B; Mintz G; Ye F; Zhang JJ; Kan J; Sun XW; Zhang AP; Chen JG; Qian J; Kwan TW
Chin Med J (Engl); 2010 Apr; 123(7):794-9. PubMed ID: 20497666
[TBL] [Abstract][Full Text] [Related]
4. In-hospital and mid-term outcomes of stent implantation in patients with protected and unprotected left main coronary artery disease; King Chulalongkorn Memorial Hospital experiences.
Cholteesupachai J; Udayachalerm W; Srimahachota S; Buddhari W; Chaipromprasit J; Songmuang SB; Suithichaiyakul T
J Med Assoc Thai; 2009 Jun; 92(6):755-60. PubMed ID: 19530580
[TBL] [Abstract][Full Text] [Related]
5. Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: a single center retrospective experience.
Simard T; Hibbert B; Chong AY; Ruchin P; Le May M; Labinaz M; Froeschl M; So D; Glover C; Marquis JF; O'Brien E
Catheter Cardiovasc Interv; 2012 Aug; 80(2):E15-22. PubMed ID: 21805580
[TBL] [Abstract][Full Text] [Related]
6. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
7. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
[TBL] [Abstract][Full Text] [Related]
8. Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study).
Sheiban I; Sillano D; Biondi-Zoccai G; Chieffo A; Colombo A; Vecchio S; Margheri M; Gunn JP; Raina T; Liistro F; Bolognese L; Lee MS; Tobis J; Moretti C
J Am Coll Cardiol; 2009 Sep; 54(13):1131-6. PubMed ID: 19761932
[TBL] [Abstract][Full Text] [Related]
9. [Short-term and long-term outcomes of treating bifurcation lesions with two drug eluting stent techniques].
Chen JL; Gao RL; Yang YJ; Qiao SB; Qin XW; Yao M; Xu B; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Dec; 34(12):1089-92. PubMed ID: 17274897
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous unprotected left main angioplasty with drug-eluting stents in a nonagenarian: feasible and safe despite recurrent restenosis.
Sillano D; Moretti C; Biondi-Zoccai G; Sheiban I
Minerva Cardioangiol; 2008 Feb; 56(1):167-70. PubMed ID: 18432178
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
[TBL] [Abstract][Full Text] [Related]
12. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
[TBL] [Abstract][Full Text] [Related]
13. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical outcomes of patients with unprotected left main bifurcation lesions treated with 2-stent techniques.
Pei HJ; Sui YG; Wu YJ; Yang YJ; Xu B; Chen JL; Qiao SB; Li JJ; Qin XW; Yao M; Yuan JQ; Chen J; Liu HB; You SJ; Gao RL
Chin Med J (Engl); 2013 Jul; 126(13):2409-13. PubMed ID: 23823809
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
[TBL] [Abstract][Full Text] [Related]
16. Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents.
De Caterina AR; Cuculi F; Banning AP
EuroIntervention; 2013 Mar; 8(11):1326-34. PubMed ID: 23538159
[TBL] [Abstract][Full Text] [Related]
17. Repeat in-stent restenosis of drug-eluting stents in a bifurcation treated successfully with kissing drug eluting balloons.
Abergel E; Beyar R; Roguin A
Cardiovasc Revasc Med; 2013; 14(2):106-8. PubMed ID: 23195308
[TBL] [Abstract][Full Text] [Related]
18. [Drug-eluting stent implantation for unprotected left main coronary artery disease: immediate and long-term outcomes].
Zhang LT; Yuan Y; Huang XS; Feng L; Liu WQ; Han Y; Zhang J; Deng ZH; Dong JT
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2257-9. PubMed ID: 19114374
[TBL] [Abstract][Full Text] [Related]
19. Incidence, predictors, treatment, and long-term prognosis of patients with restenosis after drug-eluting stent implantation for unprotected left main coronary artery disease.
Lee JY; Park DW; Kim YH; Yun SC; Kim WJ; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
J Am Coll Cardiol; 2011 Mar; 57(12):1349-58. PubMed ID: 21414531
[TBL] [Abstract][Full Text] [Related]
20. Everolimus-eluting versus paclitaxel-eluting stents for treatment of bare metal stent restenosis.
Almalla M; Schröder JW; Pross V; Stegemann E; Marx N; Hoffmann R
Am J Cardiol; 2011 Aug; 108(4):518-22. PubMed ID: 21624553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
